IRIS PubliCatt

Nero, Camilla
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 867
EU - Europa 695
AS - Asia 146
AF - Africa 12
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.728
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 860
IT - Italia 186
SE - Svezia 184
DE - Germania 128
CN - Cina 69
IE - Irlanda 66
FR - Francia 30
UA - Ucraina 28
GB - Regno Unito 24
IN - India 21
SG - Singapore 18
FI - Finlandia 13
BE - Belgio 12
IR - Iran 8
KR - Corea 8
CI - Costa d'Avorio 6
TR - Turchia 6
NL - Olanda 5
PH - Filippine 5
AT - Austria 4
CA - Canada 4
ES - Italia 4
ID - Indonesia 4
BR - Brasile 2
GF - Guiana Francese 2
HR - Croazia 2
MA - Marocco 2
MD - Moldavia 2
MX - Messico 2
MY - Malesia 2
NG - Nigeria 2
PE - Perù 2
PL - Polonia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AU - Australia 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
EG - Egitto 1
LA - Repubblica Popolare Democratica del Laos 1
NO - Norvegia 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 1.728
Salva come PNG Salva come JPEG
Città #
Chandler 255
Ashburn 107
Dublin 62
Rome 59
Ann Arbor 51
New York 35
Milan 33
San Mateo 27
Boston 23
Wilmington 21
Jacksonville 19
Princeton 19
Marseille 18
Beijing 15
Dearborn 15
Nanjing 15
Singapore 13
Cattolica 11
Nürnberg 11
Brussels 10
Fairfield 9
Leawood 9
Washington 8
Woodbridge 8
Bremen 7
Houston 7
Abidjan 6
Bari 6
Lawrence 6
Redwood City 6
Andover 5
Helsinki 5
Izmir 5
Augusta 4
Boardman 4
Changsha 4
London 4
Los Angeles 4
Madrid 4
Seattle 4
Vienna 4
Amsterdam 3
Detroit 3
Hangzhou 3
Hefei 3
Jeju City 3
Martellago 3
Nanchang 3
Norwalk 3
Sanremo 3
Shanghai 3
Toronto 3
Zhengzhou 3
Ardabil 2
Asti 2
Bollate 2
Cavite City 2
Cayenne 2
Chisinau 2
Clearwater 2
Coimbatore 2
Depok 2
Frankfurt am Main 2
Gangnam-gu 2
Genazzano 2
Hebei 2
Jinan 2
Katsina 2
Kuala Lumpur 2
Kunming 2
Lanzhou 2
Lappeenranta 2
Leipzig 2
Lima 2
Mountain View 2
Mumbai 2
Osimo 2
Oujda 2
Paris 2
Parma 2
Pasay 2
Pineto 2
Redmond 2
Rimini 2
Sala Consilina 2
Salò 2
Seoul 2
Shaoxing 2
Silver Spring 2
South Tangerang 2
Vigevano 2
Warsaw 2
Wuhan 2
Zagreb 2
Zanjan 2
Acton 1
Afragola 1
Bandar Seri Begawan 1
Berlin 1
Bratislava 1
Totale 1.063
Salva come PNG Salva come JPEG
Nome #
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience. 126
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience 108
A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessment 105
Patient-derived organoids and high grade serous ovarian cancer: from disease modeling to personalized medicine 92
Targeting the hallmarks of ovarian cancer: The big picture 76
Robotic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study 71
One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer 66
Assessment of preoperative nutritional status using BIA-derived phase angle (PhA) in patients with advanced ovarian cancer: Correlation with the extent of cytoreduction and complications 65
Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer 62
The immunohistochemical molecular risk classification in endometrial cancer: A pragmatic and high-reproducibility method 62
Laparoscopic Management of a Small Bowel Recurrence of Endometrial Cancer 61
Secondary Laparoscopic Cytoreduction in Recurrent Ovarian Cancer: A Large, Single-Institution Experience 60
Building a personalized medicine infrastructure for gynecological oncology patients in a high-volume hospital 60
Mesenteric lymph node involvement in advanced ovarian cancer patients undergoing rectosigmoid resection: Prognostic role and clinical considerations 51
Oregovomab: an investigational agent for the treatment of advanced ovarian cancer 50
Systematic Review of Cytoreductive Surgery and Bevacizumab-Containing Chemotherapy in Advanced Ovarian Cancer: Focus on Safety 46
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: utility of a scoring system to predict outcomes 45
Germline BRCA 1-2 status prediction through ovarian ultrasound images radiogenomics: a hypothesis generating study (PROBE study) 43
Pd-l1 expression on circulating tumour-derived microvesicles as a complementary tool for stratification of high-grade serous ovarian cancer patients 42
Robotic Splenectomy for Isolated Splenic Recurrence of Endometrial Adenocarcinoma 41
Emerging role of immune checkpoint inhibitors in the treatment of ovarian cancer 41
Laparotomy approach to sentinel lymph node detection in ovarian cancer using a near-infrared fluorescent system camera with indocyanine green dye 41
Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY) 40
Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification 37
Sentinel-node biopsy in early stage ovarian cancer: a prospective multicentre study (SELLY) 35
Integrating a Comprehensive Cancer Genome Profiling into Clinical Practice: A Blueprint in an Italian Referral Center 32
Newly diagnosed ovarian cancer: Which first-line treatment? 32
Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer 30
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 24
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids 20
Recent progress in the use of pharmacotherapy for endometrial cancer 20
PARP Inhibitors Resistance: Mechanisms and Perspectives 20
L1CAM Expression in Microcystic, Elongated, and Fragmented (MELF) Glands Predicts Lymph Node Involvement in Endometrial Carcinoma 15
Sentinel-node biopsy in apparent early stage ovarian cancer: final results of a prospective multicentre study (SELLY) 14
Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives 14
Advanced and recurrent endometrial cancer: State of the art and future perspectives 14
Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early-stage endometrial cancer: A propensity score–matched analysis 14
Management of stage III and IVa uterine cancer 10
Epithelial ovarian cancer and brain metastases: might the BRCA status, PARP inhibitor administration, and surgical treatment impact the survival? 6
Radiomics and Radiogenomics of Ovarian Cancer: Implications for Treatment Monitoring and Clinical Management 4
Correction: Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 4
A cost-effectiveness analysis of an integrated clinical-radiogenomic screening program for the identification of BRCA 1/2 carriers (e-PROBE study 1
Totale 1.800
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.438
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.438
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 0 0 7 2
2019/2020143 21 10 7 4 11 11 12 6 14 11 28 8
2020/2021109 9 6 6 6 14 7 6 5 10 10 23 7
2021/2022271 6 9 4 21 16 5 12 44 14 25 44 71
2022/2023684 82 89 47 111 30 87 34 48 72 15 25 44
2023/2024412 12 107 23 42 24 57 43 33 4 28 39 0
Totale 1.800